Document Detail


Clinical applications of B-type natriuretic peptide (BNP) testing.
MedLine Citation:
PMID:  14522565     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Many claims have been made in recent years regarding the utility of plasma B-type natriuretic peptide (BNP) concentration measurements in the diagnosis, risk stratification and monitoring of patients with heart failure. This paper summarizes the current evidence and provides guidance for practising clinicians. Overall, plasma BNP testing appears to be of most value in the diagnostic arena, where it is likely to improve the performance of non-specialist physicians in diagnosing heart failure. In clinical practice, BNP testing is best used as a 'rule out' test for suspected cases of new heart failure in breathless patients presenting to either the outpatient or emergency care settings; it is not a replacement for echocardiography and full cardiological assessment, which will be required for patients with an elevated BNP concentration. Although work is ongoing in establishing the 'normal' values of BNP, heart failure appears to be highly unlikely below a plasma concentration of 100 pg/ml. However, as BNP levels rise with age and are affected by gender, comorbidity and drug therapy, the plasma BNP measurement should not be used in isolation from the clinical context.
Authors:
M R Cowie; P Jourdain; A Maisel; U Dahlstrom; F Follath; R Isnard; A Luchner; T McDonagh; J Mair; M Nieminen; G Francis
Related Documents :
19183225 - Elevated ck-mb mass and plasma brain-type natriuretic peptide concentrations following ...
11176165 - Alpha-atrial natriuretic peptide, cyclic guanosine monophosphate, and endothelin in pla...
2963545 - Circadian rhythm of plasma atrial natriuretic peptide, aldosterone, and blood pressure ...
6775955 - The effect of maximal exertion on the levels of plasma peptides in cyclists with differ...
21084385 - Kisspeptin and fertility.
11293005 - Polycystic ovary syndrome and hyperprolactinemia.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  European heart journal     Volume:  24     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  2003 Oct 
Date Detail:
Created Date:  2003-10-02     Completed Date:  2003-12-10     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  England    
Other Details:
Languages:  eng     Pagination:  1710-8     Citation Subset:  IM    
Affiliation:
National Heart & Lung Institute, Imperial College, London, UK. m.cowie@imperial.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Ambulatory Care
Emergency Service, Hospital
Fluorescent Antibody Technique / methods,  standards
Heart Failure / diagnosis*
Humans
Laboratory Techniques and Procedures / standards
Luminescent Measurements
Natriuretic Peptide, Brain / blood*
Point-of-Care Systems / standards
Prognosis
Sensitivity and Specificity
Ventricular Dysfunction, Left / diagnosis
Chemical
Reg. No./Substance:
114471-18-0/Natriuretic Peptide, Brain
Comments/Corrections
Comment In:
Eur Heart J. 2004 Apr;25(7):621   [PMID:  15120064 ]
Eur Heart J. 2004 Nov;25(21):1967   [PMID:  15522477 ]
Eur Heart J. 2004 Jun;25(12):1085; author reply 1085-6   [PMID:  15191781 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The public health implications of world trade negotiations on the general agreement on trade in serv...
Next Document:  Re-assessing the contribution of serum total cholesterol, blood pressure and cigarette smoking to th...